NewH2

NewH2 is the corporate venturing subsidiary of Health & Happiness (H&H) Group, listed on the Main Board of the Stock Exchange of Hong Kong. With offices across the China, Australia, US and Europe, NewH2’s mission is to invest globally in start-ups and high growth companies with technologies and businesses of strategic importance to its parent, H&H. NewH2 is dedicated to accelerating new innovation ideas for a healthier future. The fund will focus on unique and differentiated business across health and wellness sector by partnering with businesses that are striving to disrupt and outperform industry growth. Key industry areas include: infant formula, baby care, probiotics, skin care, hair care, VHMS, lifestyle nutrition, personalised nutrition, women / pregnancy nutrition and digital technology. Impact investing is top of mind for our team, where we have an opportunity to help grow an innovative idea or brand that will also contribute positively to society and the environment. For more information above NewH2, please contact Akash Bedi, Group Director Strategy and M&A (akash.bedi@hh.global) or visit http://www.newh2.global/#